Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

2.

5-year survival of patients with AIDS receiving antiretroviral therapy in Haiti.

Leger P, Charles M, Severe P, Riviere C, Pape JW, Fitzgerald DW.

N Engl J Med. 2009 Aug 20;361(8):828-9. doi: 10.1056/NEJMc0809485. No abstract available.

3.

When to start antiretroviral therapy in resource-limited settings.

Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, Paltiel AD, Anglaret X, Weinstein MC, Losina E; CEPAC (Cost-Effectiveness of Preventing AIDS Complications)-International Investigators.

Ann Intern Med. 2009 Aug 4;151(3):157-66. Epub 2009 Jul 20.

4.

Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa.

Lawn SD, Myer L, Edwards D, Bekker LG, Wood R.

AIDS. 2009 Aug 24;23(13):1717-25. doi: 10.1097/QAD.0b013e32832d3b6d.

5.

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

When To Start Consortium, Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, Funk MJ, Geskus RB, Gill J, Dabis F, Miró JM, Justice AC, Ledergerber B, Fätkenheuer G, Hogg RS, Monforte AD, Saag M, Smith C, Staszewski S, Egger M, Cole SR.

Lancet. 2009 Apr 18;373(9672):1352-63. doi: 10.1016/S0140-6736(09)60612-7. Epub 2009 Apr 8. Review.

6.

Effect of early versus deferred antiretroviral therapy for HIV on survival.

Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Goedert JJ, Benson CA, Collier AC, Van Rompaey SE, Crane HM, McKaig RG, Lau B, Freeman AM, Moore RD; NA-ACCORD Investigators.

N Engl J Med. 2009 Apr 30;360(18):1815-26. doi: 10.1056/NEJMoa0807252. Epub 2009 Apr 1.

7.

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Hammer SM, Eron JJ Jr, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA; International AIDS Society-USA.

JAMA. 2008 Aug 6;300(5):555-70. doi: 10.1001/jama.300.5.555.

PMID:
18677028
8.

Tuberculosis and HIV infection: the global setting.

Nunn P, Reid A, De Cock KM.

J Infect Dis. 2007 Aug 15;196 Suppl 1:S5-14. Review.

PMID:
17624826
9.

The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.

Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, Sutherland D, Vitoria M, Guerma T, De Cock K.

Lancet. 2006 Aug 5;368(9534):505-10.

PMID:
16890837
10.

Antiretroviral therapy in a thousand patients with AIDS in Haiti.

Severe P, Leger P, Charles M, Noel F, Bonhomme G, Bois G, George E, Kenel-Pierre S, Wright PF, Gulick R, Johnson WD Jr, Pape JW, Fitzgerald DW.

N Engl J Med. 2005 Dec 1;353(22):2325-34.

11.
12.

Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis.

Yazdanpanah Y, Losina E, Anglaret X, Goldie SJ, Walensky RP, Weinstein MC, Toure S, Smith HE, Kaplan JE, Freedberg KA; Global AIDS Policy Model Investigators.

AIDS. 2005 Aug 12;19(12):1299-308.

PMID:
16052085
13.

A randomized trial of multivitamin supplements and HIV disease progression and mortality.

Fawzi WW, Msamanga GI, Spiegelman D, Wei R, Kapiga S, Villamor E, Mwakagile D, Mugusi F, Hertzmark E, Essex M, Hunter DJ.

N Engl J Med. 2004 Jul 1;351(1):23-32.

14.

The feasibility, demand, and effect of integrating primary care services with HIV voluntary counseling and testing: evaluation of a 15-year experience in Haiti, 1985-2000.

Peck R, Fitzgerald DW, Liautaud B, Deschamps MM, Verdier RI, Beaulieu ME, GrandPierre R, Joseph P, Severe P, Noel F, Wright P, Johnson Jr WD, Pape JW.

J Acquir Immune Defic Syndr. 2003 Aug 1;33(4):470-5.

PMID:
12869835
15.

Treatment of tuberculosis.

American Thoracic Society; CDC; Infectious Diseases Society of America.

MMWR Recomm Rep. 2003 Jun 20;52(RR-11):1-77. No abstract available. Erratum in: MMWR Recomm Rep. 2005 Jan 7;53(51):1203. Dosage error in article text.

16.

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.

Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, Jasmer RM, Koppaka V, Menzies RI, O'Brien RJ, Reves RR, Reichman LB, Simone PM, Starke JR, Vernon AA; American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society.

Am J Respir Crit Care Med. 2003 Feb 15;167(4):603-62. No abstract available.

PMID:
12588714
17.

Comprehension during informed consent in a less-developed country.

Fitzgerald DW, Marotte C, Verdier RI, Johnson WD Jr, Pape JW.

Lancet. 2002 Oct 26;360(9342):1301-2.

PMID:
12414207
18.
19.

Integration of tuberculosis screening at an HIV voluntary counselling and testing centre in Haiti.

Burgess AL, Fitzgerald DW, Severe P, Joseph P, Noel E, Rastogi N, Johnson WD Jr, Pape JW.

AIDS. 2001 Sep 28;15(14):1875-9.

PMID:
11579251
20.

Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial.

Fitzgerald DW, Desvarieux M, Severe P, Joseph P, Johnson WD Jr, Pape JW.

Lancet. 2000 Oct 28;356(9240):1470-4.

PMID:
11081529

Supplemental Content

Support Center